11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 6×
“Importantly, when intact cell systems, including primary cultures of hepatocytes (67), fibroblasts (68), adipose stromal cells (69, 70), lung (71), and cultured hippocampal cells (72), were studied, 11 -HSD1 activity was reductive in nature.”
InfluentialSelf-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationSeckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655 · cited 4×
“Some studies have described decreased ratios consistent with decreased 11 -HSD1 reductase activity with increasing body mass index (BMI) in simple obesity (140, 203).”
InfluentialShort-chain dehydrogenases/reductases (SDR): the 2002 update
Oppermann, U., Filling, C., Hult, M., Shafqat, N., Wu, X., Lindh, M., Shafqat, J., Nordling, E., Kallberg, Y., Persson, B., et al. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00164-3 · Cited by 633 · cited 1×
“This catalytic triad of residues has recently been extended to a tetrad as recent data have supported the concept that Asn111 is essential and highly conserved in most SDR forms (41, 43).”
Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases
Filling, C., Berndt, K. D., Benach, J., Knapp, S., Prozorovski, T., Nordling, E., Ladenstein, R., Jörnvall, H., & Oppermann, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202160200 · Cited by 583
Kletzien, R. F., Harris, P. K. W., & Foellmi, L. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119488 · Cited by 550 · cited 12×
“Reductase activity can be regained from tissue homogenates and purified enzyme, upon inclusion of a NADPH regeneration system employing the cytosolic enzyme glucose-6-phosphate dehydrogenase (82, 83).”
Influential11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517 · cited 3×
“Cytokines TNF Rat glomerular mesangial cells 1 164 Human preadipocytes 1 183, 184 Differentiating human sc adipocytes 1 185 Human hepatocytes 4 183 MG63 osteosarcoma cells 1 309 Human osteoblasts 1 309 Human aortic smooth muscle cells 1 374 Human bronchial smooth muscle cells 1 374 Differentiating human monocytes 4 32…”
Manolagas, S. C. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.385 · Cited by 517 · cited 1×
“In vitro they are required for the differentiation of osteoblasts but in excess can cause suppression of the mature osteoblast phenotype by reducing proliferation and inducing apoptosis (297, 298).”
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481 · cited 10×
“836 Endocrine Reviews, October 2004, 25(5):831–866 Tomlinson et al.”
InfluentialCortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458 · cited 2×
“levels in these patients are not elevated (213, 214).”
Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
Agarwal, A. K., Monder, C., Eckstein, B., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47248-7 · Cited by 455
The Aldo-Keto Reductase Superfamily
Bohren, K. M., Bullock, B., Wermuth, B., & Gabbay, K. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60566-6 · Cited by 453
Characteristics of short‐chain alcohol dehydrogenases and related enzymes
PERSSON, B., KROOK, M., & JÖRNVALL, H. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16215.x · Cited by 449 · cited 1×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439 · cited 1×
“intake, and, in addition, insulin sensitivity is enhanced (211).”
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436 · cited 5×
“Subsequently, cDNAs and proteins were published for the human (55), mouse (56), squirrel monkey (57), sheep (58), rabbit (54), pig, cow, and guinea-pig (59, 60) 11 -HSD1.”
InfluentialMasuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434 · cited 2×
“Transgenic mice overexpressing 11 -HSD1 develop hypertension as a consequence of increased circulating angiotensinogen (212).”
Paterson, J. M., Morton, N. M., Fievet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 431 · cited 1×
“glucose flux in these animals are not yet available (206).”
Sasaki, K., Cripe, T. P., Koch, S. R., Andreone, T. L., Petersen, D. D., Beale, E. G., & Granner, D. K. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42541-5 · Cited by 428 · cited 1×
“Glucocorticoids are potent regulators of many of the key enzymes involved in hepatic gluconeogenesis including PEPCK, the rate-limiting step in hepatic gluconeogenesis (197).”
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice
Screpanti, I., Romani, L., Musiani, P., Modesti, A., Fattori, E., Lazzaro, D., Sellitto, C., Scarpa, S., Bellavia, D., & Lattanzio, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07185.x · Cited by 407 · cited 1×
“Similar analysis of the related transcription factor, C/EBP , showed it to be a weak activator of 11 -HSD1 transcription, and C/EBP knockout mice (137) show increased hepatic 11 -HSD1 mRNA expression (133).”
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398 · cited 2×
“Some studies have described decreased ratios consistent with decreased 11 -HSD1 reductase activity with increasing body mass index (BMI) in simple obesity (140, 203).”
Self-citationRask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386 · cited 3×
“In obese patients this activation is impaired (140, 202, 203).”
Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population
Fraser, R., Ingram, M. C., Anderson, N. H., Morrison, C., Davies, E., & Connell, J. M. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1364 · Cited by 370 · cited 1×
“levels in these patients are not elevated (213, 214).”
Obesity and Gender Influence Cortisol Secretion and Metabolism in Man
Andrew, R., Phillips, D. I. W., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1806 · Cited by 360 · cited 1×
“Other studies have failed to show this relationship (213, 216–218) and, indeed, positive correlations have also been described (202, 219, 220).”
Livingstone, D. E. W., Jones, G. C., Smith, K., Jamieson, P. M., Andrew, R., Kenyon, C. J., & Walker, B. R. (2000) · Endocrinology · doi:10.1210/endo.141.2.7297 · Cited by 347
Reynolds, R. M., Walker, B. R., Syddall, H. E., Andrew, R., Wood, P. J., Whorwood, C. B., & Phillips, D. I. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7145 · Cited by 322
LAKSHMI, V., & MONDER, C. (1988) · Endocrinology · doi:10.1210/endo-123-5-2390 · Cited by 311
HAUNER, H., SCHMID, P., & PFEIFFER, E. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-832 · Cited by 308 · cited 1×
“Cortisol is essential for adipocyte differentiation (186), and the autocrine generation of cortisol through the action of 11 -HSD1 is able to regulate this process.”
MONDER, C., STEWART, P. M., LAKSHMI, V., VALENTINO, R., BURT, D., & EDWARDS, C. R. W. (1989) · Endocrinology · doi:10.1210/endo-125-2-1046 · Cited by 305
Self-citationJamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285 · cited 4×
“The allele frequency for the 83557A/83597T-G haplotype was 14% in control populations (84).”
InfluentialSelf-citationStewart, P. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.3.885 · Cited by 284 · cited 3×
“This relative increase in cortisone levels reflects the intense and extensive expression of 11 -HSD2 in the fetoplacental unit, notably the placental syncytiocytotrophoblast (152, 230, 231).”
Self-citationWalker, B. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3155 · Cited by 277 · cited 1×
“decreases hepatic glucose production (199).”
Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00853.x · Cited by 276 · cited 2×
“The urinary THF allo-THF:THE ratio, in the setting of a normal UFF and UFE excretion, is also believed to reflect global 11 -HSD1 activity (26).”
Self-citationBrown, R. W., Chapman, K. E., Edwards, C. R., & Seckl, J. R. (1993) · Endocrinology · doi:10.1210/endo.132.6.8504762 · Cited by 271 · cited 1×
“This relative increase in cortisone levels reflects the intense and extensive expression of 11 -HSD2 in the fetoplacental unit, notably the placental syncytiocytotrophoblast (152, 230, 231).”
Andrews, R. C., Rooyackers, O., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021194 · Cited by 266 · cited 1×
“effect on hepatic gluconeogenesis (200).”
Alberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263 · cited 1×
“2733 lowered hepatic phosphoenol pyruvate carboxykinase (PEPCK) and glucose-6-phosphatase mRNA, blood glucose, and serum insulin concentrations (121), raising the possibility that inhibition of 11 -HSD1 might be used therapeutically to treat patients with insulin resistance (see Section VII.”
Is CCAAT/enhancer-binding protein a central regulator of energy metabolism?
McKnight, S. L., Lane, M. D., & Gluecksohn-Waelsch, S. (1989) · Genes & Development · doi:10.1101/gad.3.12b.2021 · Cited by 260 · cited 1×
“C/EBP coordinately regulates a series of genes concerned with the metabolism of fuels (134), and C/EBP is regulated by glucocorticoids in a tissue-specific manner (135).”
P., A., L., E., N., E., M., F., G., K., C., L., Y., R.-N., B., Ö., & L., A. (2002) · Diabetologia · doi:10.1007/s00125-002-0959-6 · Cited by 259
Rogatsky, I., Trowbridge, J. M., & Garabedian, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3181 · Cited by 257 · cited 1×
“inhibit cellular proliferation by inducing cell cycle arrest at the G1 phase (187, 188), and the prereceptor modulation of cortisol metabolism has a dramatic effect upon cell proliferation rate (189).”
Bujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254 · cited 2×
“Importantly, when intact cell systems, including primary cultures of hepatocytes (67), fibroblasts (68), adipose stromal cells (69, 70), lung (71), and cultured hippocampal cells (72), were studied, 11 -HSD1 activity was reductive in nature.”
Self-citationKrozowski, Z., MaGuire, J. A., Stein-Oakley, A. N., Dowling, J., Smith, R. E., & Andrews, R. K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608280 · Cited by 252 · cited 1×
“This relative increase in cortisone levels reflects the intense and extensive expression of 11 -HSD2 in the fetoplacental unit, notably the placental syncytiocytotrophoblast (152, 230, 231).”
Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
Shackleton, C. H. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90132-g · Cited by 247 · cited 1×
“Reduction of the C-20 position may also occur without A ring reduction giving rise to 20 - and 20 -hydroxycortisol (12).”
Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M.-C., & Grino, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8614 · Cited by 241
Genetic Control of Susceptibility to Osteoporosis
Ralston, S. H. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2460 · Cited by 240 · cited 1×
“Several candidate genes have been identified as being important in the pathogenesis of osteoporosis (367), but to date there are no large genetic studies that have assessed the contribution of 11 -HSD1.”
Reynolds, R. M. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.245 · Cited by 239
Tanaka, N., Nonaka, T., Tanabe, T., Yoshimoto, T., Tsuru, D., & Mitsui, Y. (1996) · Biochemistry · doi:10.1021/bi951904d · Cited by 237 · cited 1×
“The regions likely to confer specificity are less well conserved, such as the potential substrate binding loop (between the F strand and the G helix), and regions in the C-terminal segment (44, 45).”
Wake, D. J., Rask, E., Livingstone, D. E. W., Söderberg, S., Olsson, T., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030286 · Cited by 231 · cited 1×
“Whereas 11 -HSD1 activity correlates well with mRNA expression in some of these studies, it does not correlate with adipose tissue cortisol concentrations (224).”
Cooper, M. S., Bujalska, I., Rabbitt, E., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., & Stewart, P. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1037 · Cited by 227 · cited 2×
“cells have clearly defined expression of 11 -HSD1 (301, 309)”
Self-citationLindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030017 · Cited by 225 · cited 1×
“More recently, several clinical studies have examined 11 -HSD1 activity in sc abdominal adipose tissue from obese men and women including a population of obese Pima Indians (140, 202, 223).”
Diaz, R., Brown, R. W., & Seckl, J. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02570.1998 · Cited by 224 · cited 3×
“However, although expression has been detected using in situ hybridization, there is little detectable enzyme activity (143).”
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
Self-citationMOISAN, M.-P., SECKL, J. R., & EDWARDS, C. R. W. (1990) · Endocrinology · doi:10.1210/endo-127-3-1450 · Cited by 221
Glucocorticoid inhibition of fsh-induced estrogen production in cultured rat granulosa cells
Hsueh, A. (1978) · Steroids · doi:10.1016/0039-128x(78)90074-0 · Cited by 220
Devoto, M., Shimoya, K., Caminis, J., Ott, J., Tenenhouse, A., Whyte, M., Sereda, L., Hall, S., Considine, E., Williams, C., et al. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200169 · Cited by 218 · cited 1×
“However, the cytogenetic localization of H6PD gene, 1p36, has been implicated for association with hip and femoral neck bone mineral density in several genome-wide scans (368, 369).”
Coenzyme-based functional assignments of short-chain dehydrogenases/reductases (SDRs)
Persson, B., Kallberg, Y., Oppermann, U., & Jörnvall, H. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00223-5 · Cited by 216 · cited 1×
“These families are now distinguished further into three subfamilies (intermediate, divergent, and complex), based on patterns of charged residues within the cosubstrate-binding region (38).”
Barf, T., Vallgårda, J., Emond, R., Häggström, C., Kurz, G., Nygren, A., Larwood, V., Mosialou, E., Axelsson, K., Olsson, R., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025530f · Cited by 211
Harris, H. J., Kotelevtsev, Y., Mullins, J. J., Seckl, J. R., & Holmes, M. C. (2001) · Endocrinology · doi:10.1210/endo.142.1.7887 · Cited by 209 · cited 1×
“Importantly, glucocorticoid-sensitive gene expression is not increased (295).”
Berger, J., Tanen, M., Elbrecht, A., Hermanowski-Vosatka, A., Moller, D. E., Wright, S. D., & Thieringer, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003592200 · Cited by 208
Multiple Factors Contribute to the Pathogenesis of Hypertension in Cushing's Syndrome
SARUTA, T., SUZUKI, H., HANDA, M., IGARASHI, Y., KONDO, K., & SENBA, S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-2-275 · Cited by 207 · cited 1×
“Studies on patients with Cushing’s syndrome (242), and in subjects given hydrocortisone (243), indicate that glucocorticoids play an important role in determining vascular reactivity in man, probably by potentiating the vasopressor action of endogenous catecholamines.”
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200 · cited 3×
“6B) with kinetics indistinguishable from those of the established endogenous glucocorticoids, cortisone and cortisol (308).”
Self-citationAbnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
Andrews, R. C., Herlihy, O., Livingstone, D. E. W., Andrew, R., & Walker, B. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020048 · Cited by 199
Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1
Ricketts, M. L., Verhaeg, J. M., Bujalska, I., Howie, A. J., Rainey, W. E., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4706 · Cited by 197
Self-citationPotentiation of hydrocortisone activity in skin by glycyrrhetinic acid
Teelucksingh, S., Mackie, A. D. R., Burt, D., Edwards, C. R. W., Mclntyre, M. A., & Brett, L. (1990) · The Lancet · doi:10.1016/0140-6736(90)92633-s · Cited by 197 · cited 1×
“In the skin, 11 -HSD1 is expressed in the epidermis, and whereas the directional activity of the enzyme at this site has not been established, the potency of topically applied hydrocortisone (as assessed by the skin vasoconstrictor assay) can be increased by glycyrrhetinic acid administration (169).”
Rodin, A., Thakkar, H., Taylor, N., & Clayton, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402173300703 · Cited by 192
Odermatt, A., Arnold, P., Stauffer, A., Frey, B. M., & Frey, F. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28762 · Cited by 190 · cited 4×
“The glucose-6-phosphate dehydrogenase enzyme of the pentose phosphate pathway has been considered to be the major source of intracellular NADPH (346), but this is a cytosolic enzyme and the membrane-binding domain of 11 -HSD1 directs the active site of the enzyme toward the ER lumen, away from the cytosol (54, 85, 347…”
InfluentialYau, J. L. W., Noble, J., Kenyon, C. J., Hibberd, C., Kotelevtsev, Y., Mullins, J. J., & Seckl, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071562698 · Cited by 190 · cited 2×
“It has been hypothesized that this is important in explaining their improved age-related learning impairments in comparison with controls (291).”
11β-Hydroxysteroid Dehydrogenase
Monder, C., & White, P. C. (1993) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60447-1 · Cited by 189
Stewart, P. M., Wallace, A. M., Atherden, S. M., Shearing, C. H., & Edwards, C. R. W. (1990) · Clinical Science · doi:10.1042/cs0780049 · Cited by 187
Self-citationTomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020687 · Cited by 187 · cited 10×
“HSD11B1 genotypes were similar in lean and obese groups, and no relationship was seen with allele length at the two polymorphic loci and BMI or WHR in either group.”
InfluentialSelf-citationCorticosteroid 11β-Dehydrogenase in Rat Testis*
PHILLIPS, D. M., LAKSHMI, V., & MONDER, C. (1989) · Endocrinology · doi:10.1210/endo-125-1-209 · Cited by 187 · cited 1×
“High levels of 11 -HSD1 were first described in the Leydig cells of the testis in 1965 (276) and subsequently confirmed by others (75, 122, 277).”
Glucocorticoid Induces Apoptosis in Rat Leydig Cells
Gao, H.-B., Tong, M., Hu, Y.-Q., Guo, Q.-S., Ge, R., & Hardy, M. P. (2002) · Endocrinology · doi:10.1210/en.143.1.130 · Cited by 185 · cited 1×
“Recently, in vitro and in vivo, glucocorticoid-induced apoptosis has been shown in Leydig cells mediated by FasL/Fas and caspase-3 pathways (288, 289).”
Whorwood, C. B., Donovan, S. J., Flanagan, D., Phillips, D. I. W., & Byrne, C. D. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1066 · Cited by 184 · cited 2×
“11 -HSD1 is also expressed in skeletal muscle (225).”
Stewart, P. M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.480 · Cited by 180 · cited 2×
“inhibits 11 -HSD2 with an inhibition constant (Ki) of 5–10 nm (73, 107).”
Self-citationTumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol Shuttle
Escher, G., Galli, I., Vishwanath, B. S., Frey, B. M., & Frey, F. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.189 · Cited by 179 · cited 1×
“11 -HSD1 is expressed in cultured rat glomerular mesangial cells where it is up-regulated by IL-1 and TNF and may modulate the antiinflammatory effects of glucocorticoids at this site (164).”
The Human Obesity Gene Map: The 2001 Update
Rankinen, T., Pérusse, L., Weisnagel, S. J., Snyder, E. E., Chagnon, Y. C., & Bouchard, C. (2002) · Obesity Research · doi:10.1038/oby.2002.30 · Cited by 179 · cited 3×
“Indeed, more than 50 different loci have been linked to obesity through genome scan and linkage studies including loci on chromosome 1 (355).”
InfluentialWhorwood, C. B. (1993) · Endocrinology · doi:10.1210/en.132.6.2287 · Cited by 178 · cited 2×
“iting 11 -HSD1 mRNA levels) (105, 106), and, in addition,”
Self-citationMoore, J. S., Monson, J. P., Kaltsas, G., Putignano, P., Wood, P. J., Sheppard, M. C., BESSER, G. M., Taylor, N., & Stewart, P. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6108 · Cited by 176
Self-citationThieringer, R., Le Grand, C. B., Carbin, L., Cai, T.-Q., Wong, B., Wright, S. D., & Hermanowski-Vosatka, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.30 · Cited by 175
Glucocorticoid-Mediated Repression of P450sccmRNA and de Novo Synthesis in Cultured Leydig Cells*
HALES, D. B., & PAYNE, A. H. (1989) · Endocrinology · doi:10.1210/endo-124-5-2099 · Cited by 173 · cited 1×
“Glucocorticoids decrease testosterone production in mouse Leydig cell cultures (279, 280), and inhibition of testicular 11 -HSD dehydrogenase activity potentiates the inhibitory effect of corticosterone on testosterone secretion in rats (281).”
Rajan, V, Edwards, C., & Seckl, Jr. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00065.1996 · Cited by 171
Laplante, M., Sell, H., MacNaul, K. L., Richard, D., Berger, J. P., & Deshaies, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.291 · Cited by 168
Role of 11β-Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries
Alzamora, R., Michea, L., & Marusic, E. T. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1099 · Cited by 168 · cited 1×
“CBX and other 11 -HSD inhibitors (including 11 HSD1 antisense oligonucleotides), through inhibition of dehydrogenase activity, potentiate noradrenaline and angiotensin II-induced vasoconstriction (25, 246, 247), enhance vasoconstriction by reducing endothelium-dependent relaxation (248), and increase Na / H exchanger…”
The ups and downs of glucocorticoid physiology Permissive and suppressive effects revisited
Munck, A., & Náray-Fejes-Tóth, A. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90091-j · Cited by 167 · cited 2×
“Growth factors GH Human sc and omental preadipocytes 4/(2) 183, 227 293T1 cells 4 227 3T3-L1 cells 4 227 Human hepatocytes 4 183 Rat hepatocytes 4/2 67, 228 Rat liver (in vivo) 2 156, 157 Hypopituitary patients 29, 226 Obese patients 380 IGF-I Human preadipocytes 2 183, 227 293T1 cells 2 227 3T3-L1 cells 2 227 Human h…”
Nordling, E., Jörnvall, H., & Persson, B. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03114.x · Cited by 167
Sun, K., Yang, K., & Challis, J. R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3681 · Cited by 163 · cited 1×
“11 -HSD1 is more abundantly expressed in chorion and decidua (152, 235, 236).”
Walker, B. R., Yau, J. L. W., Brett, L. P., Seckl, J. R., Monder, C., Williams, B. C., & Edwards, C. R. W. (1991) · Endocrinology · doi:10.1210/endo-129-6-3305 · Cited by 161
Bujalska, I. J., Walker, E. A., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8301 · Cited by 158 · cited 3×
“In addition, increasing reductase activity during adipocyte differentiation may ensure delivery of cortisol to permit continued differentiation (78).”
InfluentialSelf-citationExpression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus
Agarwal, A. K., Tusie-Luna, M.-T., Monder, C., & White, P. C. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1827 · Cited by 155 · cited 3×
“The purified enzyme behaves as a NADP-dependent dehydrogenase (52), and the switch to oxoreductase activity upon tissue homogenization (83) suggests a close association between 11 -HSD1 and a NADPH generation system.”
Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone
Cooper, M. S., Walker, E. A., Bland, R., Fraser, W. D., Hewison, M., & Stewart, P. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00344-6 · Cited by 154 · cited 2×
“Short-term (7 d) inhibition of 11 -HSD activities with CBX in normal volunteers had no impact on bone formation markers but did result in a suppression of the bone resorption markers, pyridinoline and deoxypyridinoline (307).”
Self-citationDiederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., & Bähr, V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020970 · Cited by 154
Monder, C., Miroff, Y., Marandici, A., & Hardy, M. P. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119160 · Cited by 154
Familial Polycystic Ovarian Disease
Givens, J. R. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30409-2 · Cited by 149 · cited 1×
“Epidemiological studies show that PCOS is a familial disorder with a sibling risk of 50–80% (360, 361).”
Condon, J. C., Gosden, C. M., Gardener, D., Nickson, P., Hewison, M., Howie, A. J., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5302 · Cited by 146
Self-citationVASCULAR TYPE I ALDOSTERONE BINDING SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS
Funder, J. W., Pearce, P., Smith, R., & Campbell, J. H. (1989) · Endocrinology · doi:10.1210/endo-125-4-2224 · Cited by 144 · cited 1×
“MRs have been identified in the rabbit aorta and rat mesenteric vasculature (244, 245).”
Walter, K. A., Bennett, G. N., & Papoutsakis, E. T. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.22.7149-7158.1992 · Cited by 143 · cited 1×
“11 -HSD1 belongs to the SDR superfamily, a well-established enzyme family of oxidoreductases, distinct from zinccontaining alcohol dehydrogenases (31, 32), iron-containing dehydrogenases (32), aldoketo-reductases (33), and medium-chain dehydrogenases/reductases (34).”
Payne, A. H., & SHA, L. (1991) · Endocrinology · doi:10.1210/endo-129-3-1429 · Cited by 143
Xenobiotic carbonyl reduction and physiological steroid oxidoreduction
Maser, E. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00330-o · Cited by 141 · cited 1×
“glucuronidation or sulfation facilitating excretion (103).”
Mechanisms of glucocorticoid-induced Leydig cell apoptosis
Gao, H.-B., Tong, M., Hu, Y., You, H., Guo, Q.-S., Ge, R., & Hardy, M. P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00290-3 · Cited by 135 · cited 1×
“Recently, in vitro and in vivo, glucocorticoid-induced apoptosis has been shown in Leydig cells mediated by FasL/Fas and caspase-3 pathways (288, 289).”
Ge, R., Gao, H.-B., Nacharaju, V. L., Gunsalus, G. L., & Hardy, M. P. (1997) · Endocrinology · doi:10.1210/endo.138.6.5165 · Cited by 133
Napolitano, A., Voice, M. W., Edwards, C. R. W., Seckl, J. R., & Chapman, K. E. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00200-8 · Cited by 133
Gregoire, F. M., Genart, C., Hauser, N., & Remacle, C. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90261-r · Cited by 130 · cited 1×
“In both rat and human preadipocytes, glucocorticoids exert an antiproliferative effect (190), and inhibition of 11 -HSD1 was shown to ameliorate the antiproliferative action of cortisone (Fig.”
C/EBP Regulates Hepatic Transcription of 11β-Hydroxysteroid Dehydrogenase Type 1
Williams, L. J. S., Lyons, V., MacLeod, I., Rajan, V., Darlington, G., Poli, V., Seckl, J. R., & Chapman, K. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001286200 · Cited by 130
11β-Hydroxysteroid dehydrogenase: Fact or fancy?
Monder, C., & Shackleton, C. H. L. (1984) · Steroids · doi:10.1016/s0039-128x(84)80001-x · Cited by 129
Monder, C., Sakai, R. R., Miroff, Y., Blanchard, D. C., & Blanchard, R. J. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119159 · Cited by 129 · cited 1×
“The endogenous activity of testicular 11 -HSD may explain male hormone-dependent behavior in the rat (282); dehydrogenase activity is higher in dominant male rats compared with controls and subordinates (283).”
Morton, N. M., Ramage, L. E., & Seckl, J. R. (2004) · Endocrinology · doi:10.1210/en.2003-1674 · Cited by 128 · cited 1×
“ing in other obesity-prone models (210).”
Weaver, J. U., Theventhiran, L., Noonan, K., Burrin, J. M., Taylor, N., Norman, M. R., & Monson, J. P. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb01830.x · Cited by 127
Liver X Receptors Downregulate 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
Stulnig, T. M., Oppermann, U. C. T., Steffensen, K. R., Schuster, G. U., & Gustafsson, J.-Α. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2426 · Cited by 126
ALDOSTERONE SECRETION AND METABOLISM IN NORMAL MEN AND WOMEN AND IN PREGNANCY
Jones, K. M., Lloyd‐Jones, R. L., Riondel, A. M., Tait, J. F., Tait, S. A. S., Bulbrook, R. D., & Greenwood, F. C. (1959) · European Journal of Endocrinology · doi:10.1530/acta.0.0300321 · Cited by 125 · cited 1×
“Glucocorticoids are secreted in relatively high amounts [cortisol, 15 mg/d (4, 5), corticosterone, 2 mg/d (6)] and mineralocorticoids are secreted in low amounts [aldosterone, 150 g/d (7)].”
Walker, B. R., Connacher, A. A., Webb, D. J., & Edwards, C. R. W. (1992) · Clinical Science · doi:10.1042/cs0830171 · Cited by 124 · cited 3×
“CBX and other 11 -HSD inhibitors (including 11 HSD1 antisense oligonucleotides), through inhibition of dehydrogenase activity, potentiate noradrenaline and angiotensin II-induced vasoconstriction (25, 246, 247), enhance vasoconstriction by reducing endothelium-dependent relaxation (248), and increase Na / H exchanger…”
Gelding, S. V., Taylor, N. F., Wood, P. J., Noonan, K., Weaver, J. U., Wood, D. F., & Monson, J. P. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3641180.x · Cited by 124 · cited 1×
“Studies in hypopituitary patients commencing GH therapy show a reduction in the THF allo-THF/THE ratio but no alteration in the UFF/ UFE ratio, indicative of a decrease in 11 -HSD1 reductase activity (226).”
Hammami, M. M., & Siiteri, P. K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-326 · Cited by 123
Hardy, M. P., Sottas, C. M., Ge, R., McKittrick, C. R., Tamashiro, K. L., McEwen, B. S., Haider, S. G., Markham, C. M., Blanchard, R. J., Blanchard, D. C., et al. (2002) · Biology of Reproduction · doi:10.1095/biolreprod.102.006312 · Cited by 122
Ozols, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2305 · Cited by 121 · cited 4×
“The glucose-6-phosphate dehydrogenase enzyme of the pentose phosphate pathway has been considered to be the major source of intracellular NADPH (346), but this is a cytosolic enzyme and the membrane-binding domain of 11 -HSD1 directs the active site of the enzyme toward the ER lumen, away from the cytosol (54, 85, 347…”
InfluentialYoung, M. J., Moussa, L., Dilley, R., & Funder, J. W. (2003) · Endocrinology · doi:10.1210/en.2002-220926 · Cited by 121 · cited 1×
“The expression of 11 -HSD1 in these cells and in vascular smooth muscle cells has led to speculation that it might be involved in the pathogenesis of acute coronary vascular inflammation (257).”
Low, S. C., Assaad, S. N., Rajan, V. P., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1390027 · Cited by 119 · cited 2×
“Estradiol treatment to Wistar rats decreases PEPCK expression, an effect that is dependent upon reduced 11 -HSD1 expression and the resulting decrease in hepatic corticosterone generation (173, 174, 198).”
Devoto, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2447 · Cited by 118 · cited 1×
“However, the cytogenetic localization of H6PD gene, 1p36, has been implicated for association with hip and femoral neck bone mineral density in several genome-wide scans (368, 369).”
Jamieson, A., Wallace, E. M., Andrew, R., Nunez, B. S., Walker, B. R., Fraser, R., White, P. C., & Connell, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6031 · Cited by 117 · cited 1×
“1) and have been described previously in the literature (340, 343, 344).”
Davani, B., Khan, A., Hult, M., Mårtensson, E., Okret, S., Efendić, S., Jörnvall, H., & Oppermann, U. C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000600200 · Cited by 116 · cited 2×
“11 -HSD1 is expressed in both human and rodent islets of Langerhans as well as rodent acinar cells (338).”
Tyr-179 and Lys-183 are essential for enzymatic activity of 11β-hydroxysteroid dehydrogenase
Obeid, J., & White, P. C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92373-6 · Cited by 116 · cited 2×
“An N-terminally truncated variant of rat 11 -HSD1 was expressed in COS cells and reported to be inactive (86, 87).”
Evidence for independent genetic influences on obesity in middle age.
Fabsitz, R. R., Carmelli, D., & Hewitt, J. K. (1992) · PubMed · Cited by 115
Diederich, S., Großmann, C., Hanke, B., Quinkler, M. O., Herrmann, M., Bähr, V., & Oelkers, W. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420200 · Cited by 115 · cited 3×
“cholic acid (CDCA), can also be inhibitors for 11 -HSD1 (93).”
Low, S. C., Chapman, K. E., Edwards, C. R. W., Wells, T., Robinson, I. C. A. F., & Seckl, J. R. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1430541 · Cited by 114 · cited 3×
“These clinical studies are endorsed by studies in vivo that also indicate reduction of hepatic 11 -HSD1 expression in rats treated with GH (156, 228, 229).”
The Production Rate of Cortisol in Man
Cope, C. L., & Black, E. G. (1958) · BMJ · doi:10.1136/bmj.1.5078.1020 · Cited by 113 · cited 1×
“Glucocorticoids are secreted in relatively high amounts [cortisol, 15 mg/d (4, 5), corticosterone, 2 mg/d (6)] and mineralocorticoids are secreted in low amounts [aldosterone, 150 g/d (7)].”
Whorwood, C. B., Mason, J. I., Ricketts, M., Howie, A. J., & Stewart, P. M. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03546-j · Cited by 111
Self-citationSteroid 11β-ol Dehydrogenase in Human Placenta
Osinski, P. A. (1960) · Nature · doi:10.1038/187777a0 · Cited by 110 · cited 1×
“These early studies demonstrated significant amounts of 11 -HSD activity in human placenta (19), kidney (20), and liver (21), although the “set point” of the enzyme varied, with oxidative activity (F to E) predominating in the placenta and kidney and reductive (E to F) in the liver.”
Oppermann, U. C. T., & Maser, E. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00192-4 · Cited by 110 · cited 1×
“secticides (99, 100), and carcinogens (101, 102).”
Michael, A. E., Pester, L. A., Curtis, P., Shaw, R. W., Edwards, C. R. W., & COOKE, B. A. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02147.x · Cited by 110 · cited 1×
“Glucocorticoids are known to affect ovarian function in many ways, including inhibition of FSH-stimulated aromatase activity (260), stimulation of the production of plasminogen activator in granulosa cells (261, 262), and inhibition of LH-induced steroidogenesis from granulosa-lutein cells (263).”
Rundle, S. E., Funder, J. W., Lakshmi, V. M., & Monder, C. (1989) · Endocrinology · doi:10.1210/endo-125-3-1700 · Cited by 109
Forms and functions of human SDR enzymes
Oppermann, U. C. T., Filling, C., & Jörnvall, H. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00301-x · Cited by 109 · cited 3×
“These primary structure features form essential parts of the nucleotide cofactor-binding region (Rossmann-fold) and the active site (37, 40).”
THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN
Whitworth, J. A., Stewart, P. M., Burt, D., Atherden, S. M., & Edwards, C. R. W. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01259.x · Cited by 109
Self-citationMaser, E., & Oppermann, U. C. T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00365.x · Cited by 108
Corticosteroid llβ-Dehydrogenase of Rat Tissues: Immunological Studies
Monder, C., & Lakshmi, V. M. (1990) · Endocrinology · doi:10.1210/endo-126-5-2435 · Cited by 108 · cited 1×
“High levels of 11 -HSD1 were first described in the Leydig cells of the testis in 1965 (276) and subsequently confirmed by others (75, 122, 277).”
Low, S. C., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1994) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0130167 · Cited by 108 · cited 1×
“A series of studies subsequently demonstrated that the enzyme acts as a reductase unless cells are disrupted (65, 66).”
Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparations of liver
Bush, I. E., Hunter, S. A., & Meigs, R. A. (1968) · Biochemical Journal · doi:10.1042/bj1070239 · Cited by 106 · cited 1×
“critical as androgens are also potent inhibitors (108).”
Sun, K., & Myatt, L. (2003) · Endocrinology · doi:10.1210/en.2003-0780 · Cited by 106
The short-chain alcohol dehydrogenase superfamily: Variations on a common theme
Krozowski, Z. S. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90084-1 · Cited by 106
Regional Distribution of 1 β-Hydroxysteroid Dehydrogenase in Rat Brain*
Lakshmi, V. M., Sakai, R. R., McEwen, B. S., & Monder, C. (1991) · Endocrinology · doi:10.1210/endo-128-4-1741 · Cited by 105 · cited 1×
“In situ hybridization and immunohistochemistry confirm this to be the 11 HSD1 isozyme (144, 290), and in one study, in cultured hippocampal neurons, the isozyme was shown to act predominantly as a reductase potentiating the neurotoxic effects of the inert glucocorticoid, 11-dehydrocorticosterone (72).”
PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver
Hermanowski‐Vosatka, A., Gerhold, D. L., Mundt, S. S., Loving, V. A., Lu, M., Chen, Y., Elbrecht, A., Wu, M. S., Doebber, T. W., Kelly, L. J., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3966 · Cited by 104
Maser, E., Völker, B., & Friebertshäuser, J. (2002) · Biochemistry · doi:10.1021/bi015803t · Cited by 104
Sun, K., Yang, K., & Challis, J. R. G. (1997) · Endocrinology · doi:10.1210/endo.138.11.5544 · Cited by 102
Metabolic Transformation of Hydrocortisone-4-C14 in Normal Men
Fukushima, D. K., Bradlow, H. L., HELLMAN, L., Zumoff, B., & Gallagher, T. F. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64606-x · Cited by 100 · cited 1×
“The remaining metabolites are free, unconjugated steroids (cortisol, cortisone, 6 - and 20 /20 -metabolites of cortisol and cortisone) (14).”
Voice, M. W., Seckl, J. R., Edwards, C. R. W., & Chapman, K. E. (1996) · Biochemical Journal · doi:10.1042/bj3170621 · Cited by 100
Rabbitt, E. H., Lavery, G. G., Walker, E. A., Cooper, M. S., Stewart, P. M., & Hewison, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0582com · Cited by 100 · cited 2×
“inhibit cellular proliferation by inducing cell cycle arrest at the G1 phase (187, 188), and the prereceptor modulation of cortisol metabolism has a dramatic effect upon cell proliferation rate (189).”
Self-citationTHE METABOLISM OF CORTICOSTERONE IN MAN
Peterson, R. E., & Pierce, C. E. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104091 · Cited by 99 · cited 1×
“Glucocorticoids are secreted in relatively high amounts [cortisol, 15 mg/d (4, 5), corticosterone, 2 mg/d (6)] and mineralocorticoids are secreted in low amounts [aldosterone, 150 g/d (7)].”
Cai, T.-Q., Wong, B., Mundt, S. S., Thieringer, R., Wright, S. D., & Hermanowski-Vosatka, A. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00041-3 · Cited by 98
Nikkilä, H., Tannin, G. M., New, M. I., Taylor, N., Kalaitzoglou, G., Monder, C., & White, P. C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8370690 · Cited by 98
11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone
Cooper, M. S., Blumsohn, A., Goddard, P. E., Bartlett, W. A., Shackleton, C. H. L., Eastell, R., Hewison, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022025 · Cited by 97
Self-citationDetection of glucocorticoid receptors in cultured human trabecular cells.
Weinreb, R. N., Bloom, E., Baxter, J. D., Alvarado, J. A., Lan, N. C., O'Donnell, J., & Polansky, J. R. (1981) · PubMed · Cited by 95
Liu, Y., Nakagawa, Y., Wang, Y., Li, R., Li, X., Ohzeki, T., & Friedman, T. C. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1409 · Cited by 94 · cited 2×
“reversed by recombinant leptin therapy (204).”
Draper, N. R., Echwald, S. M., Lavery, G. G., Walker, E. A., Fräser, R., Davies, E., Sørensen, T. I. A., Astrup, A. V., Adamski, J., Hewison, M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011375 · Cited by 94 · cited 2×
“Originally, the HSD11B1 gene was thought to be approximately 9 kb in size; however, the isolation and analysis of a PAC clone containing the entire human HSD11B1 gene revealed that intron 4 spans approximately 25 kb, expanding the gene size to 30 kb (131).”
Self-citationMoore, C. C., Mellon, S. H., Murai, J., Siiteri, P. K., & Miller, W. L. (1993) · Endocrinology · doi:10.1210/endo.133.1.8319583 · Cited by 93 · cited 2×
“Subsequently, 11 -HSD1 cDNAs have been cloned for a number of species including sheep (58), squirrel monkey (57), mouse (56), baboon (123), and guinea pig (59).”
An anti-inflammatory role for glucocorticoids in the ovaries?
Hillier, S. G., & TETSUKA, M. (1998) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(98)00011-4 · Cited by 92 · cited 1×
“The antiinflammatory role of glucocorticoids and its modulatory enzyme, 11 -HSD, in the ovaries is reviewed by Hillier and Tetsuka (267).”
Bland, R., Worker, C., Noble, B., Eyre, L. J., Bujalska, I., Mc, S., Stewart, P., & Hewison, M. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610455 · Cited by 92
Self-citationSteroid dehydrogenase structures, mechanism of action, and disease
Duax, W. L., Ghosh, D., & Pletnev, V. Z. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)58023-6 · Cited by 91 · cited 2×
“the protein structure to the detriment of enzyme activity (47)”
Finken, M. J. J., Andrews, R. C., Andrew, R., & Walker, B. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6009 · Cited by 91 · cited 1×
“(158), although demonstrating sex differences in A-ring re-”
Ge, R.-S., Hardy, D. O., Catterall, J. F., & Hardy, M. P. (1997) · Endocrinology · doi:10.1210/endo.138.12.5614 · Cited by 90 · cited 1×
“(77) report almost exclusive reductase activity, but it is likely that reductase activity exceeds dehydrogenase activity in immature Leydig cells but dehydrogenase activity predominates in mature adult cells (284).”
11β-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds
Maser, E., & Bannenberg, G. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90309-3 · Cited by 89
Yang, K., Smith, C. S., Dales, D. W., Hammond, G. L., & Challis, J. R. G. (1992) · Endocrinology · doi:10.1210/endo.131.5.1425412 · Cited by 88 · cited 2×
“Subsequently, 11 -HSD1 cDNAs have been cloned for a number of species including sheep (58), squirrel monkey (57), mouse (56), baboon (123), and guinea pig (59).”
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 88 · cited 1×
“fail to correct this dysregulation in obese rats (208).”
Friedberg, M. W., Zoumakis, E., Hiroi, N., Bader, T., Chrousos, G. P., & Hochberg, Z. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020510 · Cited by 87
TETSUKA, M., Fj, T., Thomas, M. J., Anderson, R. A., Mason, J. I., & Hillier, S. G. (1997) · PubMed · Cited by 87
Localization of 2 11β-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells
Brem, A. S., Bina, R. B., King, T. C., & Morris, D. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.459 · Cited by 86 · cited 1×
“To date, the evidence suggests that it is the 11 -HSD1 isoform that is predominantly expressed in the vasculature, specifically in vascular smooth muscle and cultured rat aortic endothelial cells (25, 252, 253), and here oxoreductase activity predominates (254).”
Sheppard, K. E., & Autelitano, D. J. (2002) · Endocrinology · doi:10.1210/endo.143.1.8583 · Cited by 86
Jamieson, P. M., Walker, B., Chapman, K. E., Andrew, R., Rossiter, S., & Seckl, J. R. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650685 · Cited by 86
Epithelial cell localization of type 2 11 beta-hydroxysteroid dehydrogenase in rat and human colon.
Whorwood, C. B., Ricketts, M., & Stewart, P. (1994) · Endocrinology · doi:10.1210/endo.135.6.7988441 · Cited by 85 · cited 1×
“11 -HSD activity was demonstrated in the human colon in the early 1980s (166); expression is confined to nonepithelial cells within the lamina propria of the rat colonic mucosa (167).”
Self-citationKorbonits, M., Bujalska, I. J., Shimojo, M., Nobes, J. P., Jordan, S., Grossman, A. B., & Stewart, P. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7563 · Cited by 84 · cited 3×
“Expression was absent in gonadotrophs, thyrotrophs, and, importantly, corticotrophs, suggesting that in normal physiology it does not modulate HPA axis glucocorticoid-negative feedback, at least at an autocrine level (294).”
Self-citationGao, H.-B., Ge, R., Lakshmi, V. M., Marandici, A., & Hardy, M. P. (1997) · Endocrinology · doi:10.1210/endo.138.1.4837 · Cited by 84
Rauz, S., Cheung, C. M. G., Wood, P. J., Coca‐Prados, M., Walker, E. A., Murray, P. I., & Stewart, P. (2003) · QJM · doi:10.1093/qjmed/hcg085 · Cited by 84 · cited 2×
“(319) confirmed their earlier work by showing expression of 11 -HSD1 within the NPE using in situ hybridization.”
Self-citationSánchez, I., Goya, L., Vallerga, A. K., & Firestone, G. L. (1993) · PubMed · Cited by 84
Maser, E., Richter, E., & Friebertshäuser, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0484z.x · Cited by 83 · cited 1×
“However, the association of 11 -HSD1A with carbonyl reductase activity in mouse liver suggests that it may act on substrates including xenobiotics (128, 129).”
Ricketts, M., Shoesmith, K., Hewison, M., Strain, A. J., Eggo, M. C., & Stewart, P. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560159 · Cited by 82
Self-citationHadoke, P. W. F., Christy, C., Kotelevtsev, Y. V., Williams, B. C., Kenyon, C. J., Seckl, J. R., Mullins, J. J., & Walker, B. R. (2001) · Circulation · doi:10.1161/hc4801.100077 · Cited by 82 · cited 1×
“Furthermore, enhanced vasoconstrictor and impaired relaxation responses are observed in mice lacking 11 -HSD2, but not 11 -HSD1 knockout mice (251).”
Apparent cortisone reductase deficiency: a unique form of hypercortisolism
Phillipov, G., Palermo, M., & Shackleton, C. H. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923828 · Cited by 81
Adrenocortical activity in healthy children is associated with fat mass
Dimitriou, T., Maser‐Gluth, C., & Remer, T. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.731 · Cited by 80 · cited 1×
“decreases around the time of puberty (154), and it is possible”
Glucocorticoid activity, inactivity and the osteoblast
Cooper, M. S., Hewison, M., & Stewart, P. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1630159 · Cited by 79 · cited 1×
“In vitro they are required for the differentiation of osteoblasts but in excess can cause suppression of the mature osteoblast phenotype by reducing proliferation and inducing apoptosis (297, 298).”
Self-citationGlucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort
Andrew, R., Galé, C. R., Walker, B. R., Seckl, J. R., & Martyn, C. N. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-34591 · Cited by 78
Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts
Jessen, B. A., & Stevens, G. (2002) · Gene · doi:10.1016/s0378-1119(02)01017-x · Cited by 78 · cited 1×
“Microarray data showed increased (5-fold or more) expression of 11 -HSD1 in 3T3L1 cells during differentiation across a 7-d period (194).”
Evidence for kinetically distinct forms of corticosteroid 11β-dehydrogenase in rat liver microsomes
Monder, C., & Lakshmi, V. M. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90017-4 · Cited by 78 · cited 1×
“From the pioneering studies of White and colleagues (50) and Monder and co-workers (51, 52) an 11 HSD was purified from rat liver, and an antiserum was raised against the protein and used to clone a rat cDNA although the cDNA sequence was subsequently updated in 2002 (53).”
An in vivo study of the cortisol–cortisone shuttle in subcutaneous abdominal adipose tissue
Katz, J., Mohamed-Ali, V., Wood, P., Yudkin, J., & Coppack, S. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00598.x · Cited by 78 · cited 1×
“Arteriovenous gradients of cortisol and cortisone across sc abdominal fat have also been used to assess 11 -HSD1 activity, and cortisone clearance correlates with total body fat (222).”
Increased follicular fluid total and free cortisol levels during the luteinizing hormone surge
Harlow, C. R., Jenkins, J. M., & Winston, R. M. L. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81474-4 · Cited by 74 · cited 1×
“In keeping with these data, high concentrations of cortisol have been shown to be present in follicular fluid during the LH surge (275).”
Renal Capture and Oxidation of Cortisol in Man1
HELLMAN, L., Nakada, F., Zumoff, B., Fukushima, D. K., Bradlow, H. L., & Gallagher, T. F. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-52 · Cited by 74 · cited 1×
“Isotopic studies (22) and clinical studies measuring F/E levels in patients with renal disease (23, 24) confirmed that the kidney was an important site for cortisol to cortisone conversion.”
Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA
Rajan, V., Chapman, K. E., Lyons, V., Jamieson, P. M., Mullins, J. J., Edwards, C. R. W., & Seckl, J. R. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)00159-j · Cited by 74 · cited 4×
“In rats, although not in mice (56), a similar sexual”
InfluentialTrainer, P. J., Drake, W. M., Perry, L. A., Taylor, N., BESSER, G. M., & Monson, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7664 · Cited by 72 · cited 1×
“This is supported by the observation that pegvisomant, a GH antagonist that increases endogenous GH but effectively blocks GH signal transduction and lowers IGF-I levels, reverses the reduction in the THF alloTHF/THE ratio seen in untreated acromegaly (30).”
THE METABOLISM OF CORTISOL BY HUMAN EXTRA-HEPATIC TISSUES
Jenkins, J. S. (1966) · Journal of Endocrinology · doi:10.1677/joe.0.0340051 · Cited by 72 · cited 1×
“These early studies demonstrated significant amounts of 11 -HSD activity in human placenta (19), kidney (20), and liver (21), although the “set point” of the enzyme varied, with oxidative activity (F to E) predominating in the placenta and kidney and reductive (E to F) in the liver.”
Evidence of corticosteroid action along the nephron
Marver, D. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.246.2.f111 · Cited by 72
Stokes, J., Noble, J., Brett, L., Phillips, C. I., Seckl, J. R., O'Brien, C. J., & Andrew, R. (2000) · PubMed · Cited by 70
Toogood, A. A., Taylor, N., Shalet, S. M., & Monson, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6505 · Cited by 70 · cited 1×
“The same finding was confirmed in elderly GH-deficient subjects (29).”
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Self-citationGlucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
“11β-hydroxysteroid dehydrogenases regulate the interconversion between cortisone and hormonally active cortisol, and play a role in the regulation of glucocorticoid activity [72].”
Frailty and sarcopenia: The potential role of an aged immune system
Wilson, D., Jackson, T., Sapey, E., & Lord, J. M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.01.006 · Cited by 573
“11 HSD1 activity increases with age and is induced by cytokines including TNF and IL-6 (Tomlinson et al., 2004).”
Interactions between sleep, stress, and metabolism: From physiological to pathological conditions
Hirotsu, C., Tufik, S., & Andersen, M. L. (2015) · Sleep Science · doi:10.1016/j.slsci.2015.09.002 · Cited by 495
“[111] Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, et al.”
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.